Discover app opportunities backed by real community demand signals.
-
Loading...
Automate compliance, supply chain, and performance monitoring across decentralized diagnostic lab networks
Added Dec 12, 2025
9 signals
Diagnostic companies launching decentralized testing models (like MYNZ's ColoAlert) struggle to manage quality control, kit inventory, and regulatory compliance across 150+ partner labs. Manual processes create bottlenecks for large pivotal trials and commercial scale, risking FDA audit findings and reimbursement delays.
A SaaS platform that automates partner lab onboarding, tracks diagnostic kit inventory in real-time, monitors quality metrics and turnaround times, manages regulatory documentation per site, and provides unified analytics. Ensures consistent performance across all labs while integrating with existing LIS/EHR systems.
With MYNZ targeting Q4 2025 US feasibility and 2026 pivotal PMA for ColoAlert across 150 sites, plus competitors like Shield and Cologuard scaling rapidly, decentralized diagnostics need operational infrastructure now. Manual management can't support the data demands of FDA and CMS for distributed screening programs.
No signals available